These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24330811)

  • 1. Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis.
    Pollak TA; McCormack R; Peakman M; Nicholson TR; David AS
    Psychol Med; 2014 Sep; 44(12):2475-87. PubMed ID: 24330811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
    Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
    JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
    Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
    Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.
    Kruse JL; Lapid MI; Lennon VA; Klein CJ; Toole OO; Pittock SJ; Strand EA; Frye MA; McKeon A
    Psychosomatics; 2015; 56(3):227-41. PubMed ID: 25975857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-NMDA receptor antibody positivity in acute psychotic states: An exploratory study.
    Bharadwaj B; Sathyanarayanan G; Kaliaperumal V; Dhodapkar R
    Asian J Psychiatr; 2019 Jun; 43():95-98. PubMed ID: 31121536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.
    Pearlman DM; Najjar S
    Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.
    Tsutsui K; Kanbayashi T; Tanaka K; Boku S; Ito W; Tokunaga J; Mori A; Hishikawa Y; Shimizu T; Nishino S
    BMC Psychiatry; 2012 May; 12():37. PubMed ID: 22569157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.
    Ando Y; Shimazaki H; Shiota K; Tetsuka S; Nakao K; Shimada T; Kurata K; Kuroda J; Yamashita A; Sato H; Sato M; Eto S; Onishi Y; Tanaka K; Kato S
    BMC Psychiatry; 2016 Jul; 16():226. PubMed ID: 27391811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Encephalitis in Postpartum Psychosis.
    Bergink V; Armangue T; Titulaer MJ; Markx S; Dalmau J; Kushner SA
    Am J Psychiatry; 2015 Sep; 172(9):901-8. PubMed ID: 26183699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children.
    Pathmanandavel K; Starling J; Merheb V; Ramanathan S; Sinmaz N; Dale RC; Brilot F
    Biol Psychiatry; 2015 Mar; 77(6):537-47. PubMed ID: 25168608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: Case report.
    Kramina S; Kevere L; Bezborodovs N; Purvina S; Rozentals G; Strautmanis J; Viksna Z
    Psych J; 2015 Dec; 4(4):226-30. PubMed ID: 26663628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.
    Tong J; Huang J; Luo X; Chen S; Cui Y; An H; Xiu M; Tan S; Wang Z; Yuan Y; Zhang J; Yang F; Li CR; Hong LE; Tan Y
    Brain Behav Immun; 2019 Oct; 81():213-219. PubMed ID: 31201848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia.
    Masopust J; Andrýs C; Bažant J; Vyšata O; Kuca K; Vališ M
    Neuropsychiatr Dis Treat; 2015; 11():619-23. PubMed ID: 25834440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis.
    Deakin J; Lennox BR; Zandi MS
    Biol Psychiatry; 2014 Feb; 75(4):284-91. PubMed ID: 23988024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies and Psychosis.
    Kelleher E; Barry H; Cotter DR; Corvin A; Murphy KC
    Curr Top Behav Neurosci; 2020; 44():85-123. PubMed ID: 31292938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of Antibodies against NMDA Receptor: Molecular Insights into Autoimmune Psychosis.
    Jézéquel J; Johansson EM; Leboyer M; Groc L
    Trends Neurosci; 2018 Aug; 41(8):502-511. PubMed ID: 29807730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study.
    Kelleher E; McNamara P; Dunne J; Fitzmaurice B; Heron EA; Whitty P; Walsh R; Mooney C; Hogan D; Conlon N; Gill M; Vincent A; Doherty CP; Corvin A
    Schizophr Res; 2020 Aug; 222():455-461. PubMed ID: 32499165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosis.
    Beck K; Lally J; Shergill SS; Bloomfield MA; MacCabe JH; Gaughran F; Howes OD
    Br J Psychiatry; 2015 Feb; 206(2):164-5. PubMed ID: 25431428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis.
    Guasp M; Giné-Servén E; Maudes E; Rosa-Justicia M; Martínez-Hernández E; Boix-Quintana E; Bioque M; Casado V; Módena-Ouarzi Y; Guanyabens N; Muriana D; Sugranyes G; Pacchiarotti I; Davi-Loscos E; Torres-Rivas C; Ríos J; Sabater L; Saiz A; Graus F; Castro-Fornieles J; Parellada E; Dalmau J
    Neurology; 2021 Jul; 97(1):e61-e75. PubMed ID: 33980703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.